Article
The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579.
The EMBO journal - 15 Feb 1999
Hoffmann R, Baillie G S, MacKenzie S J, Yarwood S J, Houslay M D
Abstract excerpt
The extracellular receptor stimulated kinase ERK2 (p42(MAPK))-phosphorylated human cAMP-specific phosphodiesterase PDE4D3 at Ser579 and profoundly reduced ( approximately 75%) its activity. These effects could be reversed by the action of protein phosphatase PP1. The inhibitory state of PDE4D3, engendered by ERK2 phosphorylation, was mimicked by the Ser579-->Asp mutant form of PDE4D3. In COS1 cells transfected to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
